935106861
info@markelab.com
Precio
375€ (100 µg)
Leronlimab is a monoclonal antibody biosimilar expressed in CHO cells, targeting CCR5/CD195, Leronlimab (PRO140) is a humanized IgG4 monoclonal antibody that can target to block chemokine receptor 5 (CCR5), a cell receptor used in HIV infection, tumor metastasis, and immune signal transduction Play multiple roles.
Biosimilars
Human
Monoclonal
Human
CCR5/CD195
Human
IgG4 Kappa
Unconjugated
Liquid
ELISA, WB
100 µg
1 mg
Recombinant
> 95%
Purified from cell culture supernatants by Protein A/G chromatography.
0.01 M PBS. pH 7.4.
Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
No
Shipped within 7-12 working days.
Biosimilars
CAS Number 674782-26-4
Precio a consultar
Ver másPrecio a consultar
Ver másPrecio a consultar
Ver más